About
Develops a technology to create three-dimensional microtumors (spheroids) from patient tissue samples that closely mimic the original tumor, enabling ex vivo testing of cancer drugs and drug combinations to inform treatment decisions.
Explore SpheroTec GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.